Centre Hospitalier Universitaire Dijon
Clinical trials sponsored by Centre Hospitalier Universitaire Dijon, explained in plain language.
-
Heart surgery drug trial aims to stop kidney failure
Disease control OngoingThis study is testing whether using the drug vasopressin to maintain blood pressure after heart surgery is better at preventing kidney failure or death than the standard drug, noradrenaline. It involves 840 adults at high risk for kidney problems who are having planned heart surg…
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Cheaper drug challenge: can methotrexate match expensive treatment for dangerous blood vessel disease?
Disease control OngoingThis study compares two drugs, methotrexate and tocilizumab, to control giant cell arteritis—a serious inflammatory blood vessel disease that can cause vision loss. Both aim to keep the disease in remission while reducing patients' need for long-term steroid treatments, which oft…
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Trial aims to find best way to stop powerful arthritis drug, reduce costs and side effects
Disease control OngoingThis study is for people with giant cell arteritis, an inflammatory blood vessel disease, who have been in remission for at least 12 weeks while taking the drug tocilizumab. It compares two methods for stopping the medication: quitting immediately versus a slow, gradual reduction…
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
One shot could halve surgery complications for cancer patients
Disease control OngoingThis large study is testing if a single, high dose of steroids given right before surgery can help patients recover better from operations for digestive cancers like colon or pancreatic cancer. The goal is to reduce harmful inflammation that can lead to serious complications and …
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC